Assessing the Viability of Segmental Aneuploid Embryos: A Chromosomal Concordance Study of 175 Human Blastocysts
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115284 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von En-Hui Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Diagnosis Laboratory, Lee Women's Hospital, Taichung 40652, Taiwan. Hauptthemen laut MEDLINE: Aneuploidy, Blastocyst, Preimplantation Diagnosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council of Taiwan.
Abstract (Originalsprache)
Preimplantation genetic testing for aneuploidy (PGT-A) is widely used to select euploid embryos for in vitro fertilization (IVF), but its accuracy in predicting the implantation potential for full segmental aneuploid (Seg-A) embryos remains unclear. In this study, we investigated chromosomal concordance between clinically biopsied trophectoderm (TE) and inner cell mass (ICM) in 175 donated blastocysts, which comprised those clinically diagnosed as euploid (13), Seg-A (36), segmental mosaicism (Seg-M) (60), whole-chromosome aneuploid (Who-A) (52), and whole-chromosome mosaicism (14). Using next-generation sequencing (NGS), we found that TE–ICM concordance rates were higher for euploid (85%) and Who-A (94%) embryos but significantly lower for Seg-A (25%) and Seg-M embryos (33%). For Seg-A, the euploidy rate in the ICM was 19% and the euploidy rate in the ICM was 63% for Seg-M. These low concordance rates may be due to technical and biological artifacts of PGT-A for Seg-A. Despite the significant discordance between TE and ICM, a subset of Seg-A embryos demonstrated euploidy. While clinically diagnosed euploid embryos remain the preferred choice, Seg-A embryos should be considered as having implantation potential. In particular, Seg-A results should be clearly distinguished from Who-A results and not routinely categorically discarded. Further research is required to refine the selection criteria, aided by parental karyotyping or re-biopsy, and to develop more reliable embryo assessment methods to ensure the accurate evaluation of reproductive potential and support shared decision making between doctors and patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetic Diagnosis Laboratory, Lee Women's Hospital, Taichung 40652, Taiwan.
- Post Baccalaureate Medicine, National Chung Hsing University, Taichung 40227, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Division of Infertility, Lee Women's Hospital, Taichung 40402, Taiwan.
- Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
- Department of Obstetrics and Gynecology, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
ORCID-Profile: Hui-Hsin Shih, Tsung-Hsien Lee, Pin-Yao Lin, Tzu-Ning Yu, Chun-Chia Huang, Chun-I Lee
Förderung
- National Science and Technology Council of Taiwan
Zitieren
APA
Cheng, E. H., Shih, H. H., Lee, T. H., Lin, P. Y., Yu, T. N., Huang, C. C., Lee, M. S., & Lee, C. I. (2025). Assessing the Viability of Segmental Aneuploid Embryos: A Chromosomal Concordance Study of 175 Human Blastocysts. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115284
Vancouver
Cheng EH, Shih HH, Lee TH, Lin PY, Yu TN, Huang CC, et al. Assessing the Viability of Segmental Aneuploid Embryos: A Chromosomal Concordance Study of 175 Human Blastocysts. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115284
BibTeX
@article{Cheng2025,
author = {Cheng, En-Hui and Shih, Hui-Hsin and Lee, Tsung-Hsien and Lin, Pin-Yao and Yu, Tzu-Ning and Huang, Chun-Chia and Lee, Maw-Sheng and Lee, Chun-I},
title = {Assessing the Viability of Segmental Aneuploid Embryos: A Chromosomal Concordance Study of 175 Human Blastocysts},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115284}
}
EUVIMED